EUVIMEDEUVIMED entdecken
Crossref

Impact of Financial Toxicity in Surgical Oncology Patients on Postoperative Hospital Readmission

Michelle M Dugan iD, Rachel Pruett, Dino Romero, Joshua P Parreco, Courtney M Edwards, Jessica L Buicko

The American Surgeon™ · 2025

DOI: 10.1177/00031348251346531 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Surgeon™, 2025. Verfasst von Michelle M Dugan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Florida Atlantic University Schmidt College of Medicine, Boca Raton, FL, USA. Hauptthemen laut MEDLINE: Patient Readmission, Neoplasms, Postoperative Complications, Surgical Oncology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Financial toxicity can lead to poor outcomes in surgical oncology patients. This study evaluates the impact of financial toxicity on readmissions in surgical oncology patients, including different-hospital readmissions.

Methods

The Nationwide Readmissions Database was queried for patients admitted with a surgically treated malignancy. Financial toxicity was defined by at least two: lack of insurance, household income in the lowest quartile, or index hospitalization cost in the highest quartile.

Results

Of 108,850 patients, the 30-day readmission rate was 17.4% (n = 18,959), with 19.1% (n = 3,611) readmitted to a different hospital. Financial toxicity was identified in 7.3% (n = 7,888), with a readmission rate of 20.1% (n = 1,585; P < .001). On multivariable regression, the strongest risk factors for readmission were more than 3 comorbidities (OR 1.74 [1.68-1.79]; P < .001), and financial toxicity (OR 1.11 [1.05-1.18]; P < .001).

Conclusion

Surgical oncology patients impacted by financial toxicity are at an increased risk for readmission. Readmission studies from single institutions miss a large portion of these patients with this compounding risk. Outcome improvements can be achieved by reducing financial burdens placed on surgical oncology patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient ReadmissionNeoplasmsPostoperative ComplicationsSurgical OncologyFinancial StressHumansFemaleMaleMiddle AgedAgedRisk FactorsUnited StatesDatabases, FactualAdultRetrospective Studies

Stichwörter der Autor:innen

costfinancial toxicityreadmissionsurgical oncology

Autor:innen und Institutionen

  • Department of General Surgery, Florida Atlantic University Schmidt College of Medicine, Boca Raton, FL, USA.
  • Department of General Surgery, Memorial Healthcare System, Hollywood, FL, USA.
  • Department of Surgery, McGovern Medical School at UTHealth, Houston, TX, USA.

ORCID-Profile: Michelle M Dugan

Zitieren

APA

Dugan, M. M., Pruett, R., Romero, D., Parreco, J. P., Edwards, C. M., & Buicko, J. L. (2025). Impact of Financial Toxicity in Surgical Oncology Patients on Postoperative Hospital Readmission. The American Surgeon™. https://doi.org/10.1177/00031348251346531

Vancouver

Dugan MM, Pruett R, Romero D, Parreco JP, Edwards CM, Buicko JL. Impact of Financial Toxicity in Surgical Oncology Patients on Postoperative Hospital Readmission. The American Surgeon™. 2025. doi:10.1177/00031348251346531

BibTeX
@article{Dugan2025,
  author = {Dugan, Michelle M and Pruett, Rachel and Romero, Dino and Parreco, Joshua P and Edwards, Courtney M and Buicko, Jessica L},
  title = {Impact of Financial Toxicity in Surgical Oncology Patients on Postoperative Hospital Readmission},
  journal = {The American Surgeon™},
  year = {2025},
  doi = {10.1177/00031348251346531}
}
Kostenlos starten →